Clinical Study

Stand-Alone Lateral Interbody Fusion for the Treatment of Low-Grade Degenerative Spondylolisthesis

Table 1

Demographic and clinical data.

Patients (n)52
Age (years)67.6 ± 10.0
Female 38 (73.1%)
BMI (m/kg2) 27.4 ± 3.3
Pre-op VAS77.9 ± 21.8
Pre-op ODI 66.0 ± 16.8
Olisthesis 15.1%  ± 5%
Spine levels52
 L1-2 2 (3.8%)
 L2-3 9 (17.3%)
 L3-4 14 (26.9%)
 L4-5 27 (51.9%)
Blood loss (cc) <50
Surgery duration (min) 73.2 ± 31.4